Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer

This study has been completed.
Sponsor:
Information provided by:
AGO Study Group
ClinicalTrials.gov Identifier:
NCT00102375
First received: January 29, 2005
Last updated: August 3, 2006
Last verified: February 2006